Skip to main content
. 2024 Jan 19;10(3):e24774. doi: 10.1016/j.heliyon.2024.e24774

Fig. 2.

Fig. 2

The scatter plots of Mendelian randomization results: (A) Psoriasis and Migraine; (B) Psoriasis and Parkinson's disease; (C) Psoriasis and Multiple Sclerosis; (D) Psoriasis and epilepsy. SNP, single-nucleotide polymorphism; MR, Mendelian randomization. The slope of the scatter plot represents the magnitude of the impact of psoriasis on central neurological disorders.